1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > China Pharmaceutical Raw Materials Mfg. Industry Data Report

China Pharmaceutical Raw Materials Mfg. Industry Data Report

  • December 2014
  • -
  • Beijing Zeefer Consulting Ltd
  • -
  • 22 pages

This data report provides key statistics and concise analysis on pharmaceutical raw materials mfg. industry in China. It presents an overview on pharmaceutical raw materials mfg. industry's overall performance for the year 2011 to 2013, and reveals differences in various regions of Mainland China in terms of pharmaceutical raw materials mfg. sector, provides an important reference for investors' selection of target regions to make investment based on Zeefer Industry Distribution Index.

Features and Benefits you will get:

- Market / industry size in terms of sales revenue and number of enterprises, with 3 years growth rate;
- A clear picture on how pharmaceutical raw materials mfg. industry performed in different regions by a visible data map;
- Quantitative figures to easily compare and contrast the regional development status in term of the pharmaceutical raw materials mfg. industry based on the calculation of Zeefer Industry Distribution Index, as well as other industry statistics;
- Comparison between foreign invested companies, state owned companies, private companies as well as other types of companies;
- Profitability, solvency, turnover ability and loss, four aspects to describe current pharmaceutical raw materials mfg. industry development situation.

Key statistic indicators covered:

- Number Of Employees
- Enterprise Number
- Sales Revenue
- Profits
- Rate Of Return On Sales
- Rate Of Return On Assets
- Asset-liability Ratio
- Ratio of Receivable in Current Assets
- Asset Turnover
- Receivable Turnover
- Number Of Enterprises In Red
- Range Of Loss
- Total Losses
- GDP
- Growth Rate Of GDP
- Growth Rate Of The Added Value Of Primary Industry
- Growth Rate Of The Added Value Of Secondary Industry
- Growth Rate Of The Added Value Of The Tertiary Industry
- Industrial Value-Added Of Enterprises Above Designated Size
- Growth Rate Of Industrial Value-Added Of Enterprises Above Designated Size
- ......

Enterprises types covered:

- Enterprises Funded by Foreign Countries (territories), Hong Kong, Macau and Taiwan
- Chinese State-owned Enterprises
- Collective-owned Enterprises
- Cooperative Enterprises
- Joint-Equity Enterprises
- Private Enterprises

This report is based on Chinese industry classification (Industrial Classification For National Economic Activities, GB/T 4754-2011).

Table Of Contents

China Pharmaceutical Raw Materials Mfg. Industry Data Report
1. Industry Definition and Proportion of Sales Revenue for each Sub-industries
2. The Nationwide Distribution of Pharmaceutical Raw Materials Mfg. Industry In China
3. Industry Overview
4. Number of Enterprises and Growth Rate
5. Sales Revenue and Growth Rate
6. Profit and Growth Rate
7. Assets and Growth Rate
8. Financial Ratio
8.1. Profitability
8.2. Solvency
8.3. Turnover Ability
9. Industry Loss Status
9.1. Number of Enterprises in Red and Growth Rate
9.2. Total Amount of Loss and Growth Rate
9.3. Percentage of Enterprises in Red in Pharmaceutical Raw Materials Mfg. Industry and Average Amount of Loss
10. Operating Status by Enterprise Ownerships
11. Operating Status of Enterprises by Major Provinces
12. An Overview on Chinese Economy
13. Index Explanation

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.